At the IGTP TODAY

News

The Core Facilities of the Can Ruti Campus: cutting-edge technology driving excellence in research

At the Campus Can Ruti Core Facilities Infoday, the Josep Carreras Leukaemia Research Institute and the Germans Trias i Pujol Research Institute showcased their scientific services and the support they can offer to research conducted both on the campus and externally. The event also featured the presentation of the new IGTP-IJC Joint Flow Cytometry Unit, which has one of the most advanced infrastructures in the EU, as well as the new IJC's Translational-PATH2CURE hub, which aims to accelerate the translation of scientific discoveries into treatments for patients.

The Fundació Catalunya La Pedrera awards 33 Talents Grants to retain medical and research talent in Catalonia

The Talents Grants for the 2024 and 2025 editions have been granted by the Fundació Catalunya La Pedrera, supporting healthcare professionals in developing research projects that will lead to their doctoral theses. This initiative, originally created through a collaboration with the Research Institute and Hospital Germans Trias i Pujol, now also includes Hospital Clínic Barcelona, the Vall d'Hebron Institute of Oncology and Hospital de Bellvitge.

Awards for Research Career in Primary Care and for Best Article at the 16th Conference of Institut Català de la Salut, focused on cancer

The conference has been a meeting point and an opportunity to share strategies, knowledge and innovative projects that contribute to improving the health and quality of life of people affected by cancer. Pere Torán and Federico Fondelli, researchers affiliated with IGTP, have been recognised in the 2025 Research Awards.

Precision increases in a project led by Germans Trias using AI to detect early facial changes in patients with acromegaly

A project led by the Germans Trias i Pujol University Hospital and Research Institute has developed an AI-based facial recognition system, AcroFace, capable of detecting early signs of acromegaly with 93% accuracy. The researchers are now conducting a larger pilot study with 4,000 images from the general population to confirm these promising results and improve early diagnosis of this rare disease.